Slate Path Capital’s Confluent CFLT Stock Holding History

Slate Path Capital’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,580,000	Closed	-$83.9M	–	49
2025 Q1	$83.9M	Buy	+3,580,000	New	+$104M	1.52%	28

Other funds holding CFLT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $9.83B AUM 24.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Slate Path Capital's CFLT Position: Q2 2025 in Review

Slate Path Capital sold out of Confluent (CFLT) in Q2 2025, closing a stake of 3,580,000 shares — an estimated $83.9M sold.

Slate Path Capital first reported a position in CFLT in Q1 2025 and held it in 1 quarter. The position peaked at $83.9M in Q1 2025. 396 funds tracked by Wall St. Rank hold CFLT as of Q2 2025.

Slate Path Capital reported no remaining Confluent position as of Q2 2025 after selling out during the quarter.
Slate Path Capital sold 3,580,000 Confluent shares in Q2 2025, an estimated $83.9M.
Slate Path Capital first reported a position in Confluent in Q1 2025 and held it in 1 quarter.
Slate Path Capital's Confluent position peaked at $83.9M in Q1 2025.
396 funds tracked by Wall St. Rank held Confluent as of Q2 2025.

Based on Slate Path Capital's 13F filing for Q2 2025, filed 14 Aug 2025.